Skip to content

Treatment of Vascular Lesions With a Tandem 532/1064 nm Laser

Treatment of Vascular Lesions With a Tandem 532/1064 nm Laser

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00585338
Enrollment
1
Registered
2008-01-03
Start date
2007-12-31
Completion date
2010-10-31
Last updated
2022-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vascular Lesion

Keywords

facial telangiectasia,, leg vein telangiectasia, Port Wine Stain birthmarks

Brief summary

Dermatologists have for many years treated vascular lesions by a variety of modalities including cryosurgery, electrotherapy, dermabrasion and radiation. It has been hypothesized that simultaneous delivery of these two wavelengths may provide safer, and in some cases more effective, vascular lesion removal. The Tandem laser is capable of emitting multiple cryogen spurts intermittently with multiple 532/1064 nm laser pulses.This mode may reduce malformed blood vessels with a low incidence of long-term side effects.

Detailed description

The researcher can determine the blanching of vascular lesions after Tandem laser with multiple 532/1064 nm laser pulses treatment. The researcher will select one to four test sites spots for laser treatment. will be Different laser parameters can be used for each test site. The research will evaluate of the test sites at 6-12 weeks for bruising and blanching. Parameters of the test area with the greatest degree of blanching without adverse effects will be utilized for further treatment. If no test area is determined to have blanching without adverse effects, further test sites may be performed.

Interventions

DEVICETandem 532/1064 nm Laser

Treatment of Vascular Lesions With a Tandem 532/1064 nm Laser

Sponsors

Beckman Laser Institute University of California Irvine
CollaboratorOTHER
University of California, Irvine
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult age 18 years and older * Diagnosis of vascular lesion

Exclusion criteria

* Age \<18 * Pregnancy * History of cutaneous photosensitivity * Any therapy to the proposed treatment sites within the previous two months * Current participation in any other investigational drug or device evaluation

Design outcomes

Primary

MeasureTime frameDescription
Laser treatment6 monthsTreatment of Vascular Lesions With a Tandem 532/1064 nm Laser

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026